Journal Information
Vol. 31. Issue 7.
Pages 371-372 (October 1995)
Vol. 31. Issue 7.
Pages 371-372 (October 1995)
Full text access
Réplica
Visits
2985
M. Miravitlles, R. Vidal
Servicio de Ncumologia. Hospital General Universitario Valí d’Hcbron. Barcelona
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
N. Anthoniscn.
Design of a clinical trial to test a treatment of the underlying cause of emphysema.
Ann NY Acad Sci, 624 (1991), pp. 31-34
[2.]
M. -Wencker, J. Denker, N. Konietzko.
Serial measurements of FEV1 over 12 years in a patient with alpha-1-protease inhibitor defieiency: influence of augmentaron thcrapy and infections.
Respiraron, 61 (1994), pp. 195-198
[3.]
E.D. Janus, N.T. Phillips, R.W. Carrell.
Smoking, lung function, and alpha-1-antitrypsin defíciency.
Lancet, 1 (1985), pp. 152-154
[4.]
M. Miravitlles, R. Vidal, M. Torrella, J.M. Bofill, M. Cotrina, J. De Gracia.
Evaluación del tratamiento sustitutivo del enfisema por déficit de alfa-1-antitripsina.
Arch Bronconeumol, 30 (1994), pp. 479-484
[5.]
M. Miravitlles, R. Vidal, J. De Gracia.
Enfisema pulmonar por déficit de alfa-1-antitripsina.
Situación actual y nuevas perspectivas para el tratamiento. Arch Bronconeumol, 28 (1992), pp. 296-302
[6.]
N. Konictzko.
Alpha-1-antitrypsin substitution treatment or prevention of emphysema.
Lung, 168 (1990), pp. 592-598
[7.]
P. De Caries, J. Constans, M.C. Pujazon, J. Arnaud, D. Lauque, M. Goudemand.
Bilan á deux ans du traitement substitutif de l’emphyséme PiZZ par l’alpha-1-antitrypsine.
Ncuf cas. Presse Méd, 19 (1990), pp. 514-518
[8.]
A.F. Barker, F. Siemsen, D. Pasley, R. D'Silva, S. Buist.
Replacement therapy for hereditary alpha-1-antitrypsin defíciency. A program for long-term administration.
Chest, 105 (1994), pp. 1.406-1.410
[9.]
A. Dirksen, F. Madsen, C.S. Ulrik, et al.
A randomized placebo-controlled pilot study of alpha-1-protease inhibitor replacement therapy monitored by daily spirometry.
Am Rev Respir Dis, 147 (1993), pp. 325A
[10.]
M.D. Wewers, M.A. Casolaro, R.G. Crystal.
Comparison of alpha-l-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-l-antitrypsin phenotype nuil-nuil before and during alpha-l-antitrypsin augmentation therapy.
Am Rev Respir Dis, 135 (1987), pp. 539-543
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica